1997
DOI: 10.1016/s0190-9622(18)30752-7
|View full text |Cite
|
Sign up to set email alerts
|

Eruptive keratoacanthomas associated with immunosuppressive therapy in a patient with systemic lupus erythematosus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2001
2001
2018
2018

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 22 publications
0
3
0
Order By: Relevance
“…14 They can present as solitary lesions, multiple lesions (generalized eruptive keratoacanthomas of Gryzbowski), 15 familial syndromes (familial keratoacanthomas of the Ferguson-Smith), 10 within the context of genetic disorders (Muir-Torre syndrome), 16 or associated with immunosuppressive therapy. 17,18 They have also been noted as a postoperative complication around surgical sites for skin cancer excision. 19 Squamous cell carcinoma has an associated risk of metastatic risk, which reinforces the importance of early identification and treatment.…”
Section: Squamous Cell Carcinomamentioning
confidence: 99%
“…14 They can present as solitary lesions, multiple lesions (generalized eruptive keratoacanthomas of Gryzbowski), 15 familial syndromes (familial keratoacanthomas of the Ferguson-Smith), 10 within the context of genetic disorders (Muir-Torre syndrome), 16 or associated with immunosuppressive therapy. 17,18 They have also been noted as a postoperative complication around surgical sites for skin cancer excision. 19 Squamous cell carcinoma has an associated risk of metastatic risk, which reinforces the importance of early identification and treatment.…”
Section: Squamous Cell Carcinomamentioning
confidence: 99%
“…38,39 Keratoacanthomas have been reported in a patient with impaired cellular immunity and autoimmune hemolytic anemia 40 and in a patient with systemic lupus erythematosis who was on immunosuppressive medications. 41 One MTS patient with alpha 1 antitrypsin de®ciency and necrotizing vasculitis developed multiple sebaceous adenomas and keratoacanthomas during immunosuppressive therapy for necrotizing vasculitis. 42 Many patients with MTS had underlying hematological malignancies and impaired immunity: 6 non-Hodgkin's lymphoma, 4 chronic lymphocytic leukemia, and 4 Hodgkin's disease (our unpublished data).…”
Section: Sebaceous Tumors and Immunologic Disordersmentioning
confidence: 99%
“…Other risk factors include immunosuppression, skin trauma (e.g. surgical procedures, chemical peeling, dermabrasion, cryotherapy, photodynamic therapy or irritation after application of tar and imiquimod), and treatment with BRAF inhibitors and Hedgehog pathway inhibitors [13,14]. Clinically, it may present as a solitary lesion or as multiple lesions (Ferguson-Smith type) [14,15].…”
mentioning
confidence: 99%